Molecules 1998, 3(3), 107-119; https://doi.org/10.3390/30300107
Enantiodivergent Synthesis of (R)- and (S)-Rolipram
Preclinical Research, Novartis Pharma Ltd, CH-4002 Basel, Switzerland
*
Author to whom correspondence should be addressed.
Received: 2 November 1997 / Accepted: 23 February 1998 / Published: 10 March 1998
Abstract
Both enantiomers of rolipram (1) have been prepared in large quantity from a common intermediate rac-3-(3’-cyclopentyloxy-4’-methoxy)phenyl-4-nitro butyric acid (6), which was resolved by way of the two readily separable diastereoisomeric amides obtained with (S)-(-)-phenylethylamine. Reduction of the nitro group and intramolecular transamidation gave (R)-(-)-1 and (S)-(+)-1, respectively. CD spectra of both enantiomers of rolipram are reported and discussed. Both enantiomers of rolipram presented the same potency of inhibitory activity against recombinant cyclic-AMP-selective phosphodiesterase (PDE4) subtypes. View Full-Text
Figure 1
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
Share & Cite This Article
MDPI and ACS Style
Demnitz, J.; LaVecchia, L.; Bacher, E.; Keller, T.H.; Müller, T.; Schürch, F.; Weber, H.-P.; Pombo-Villar, E. Enantiodivergent Synthesis of (R)- and (S)-Rolipram. Molecules 1998, 3, 107-119.
Related Articles
Article Metrics
Comments
[Return to top]
Molecules
EISSN 1420-3049
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert